Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee
- 13 January 2016
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 31 (6) , 529-534
Abstract
Purpose: Hematopoietic Progenitor Cell (HPC) collection by apheresis is performed in patients and donors to obtain HPCs for transplantation. Although studies have shown these procedures to be safe, successful collection cannot be performed without establishment of venous access. This project's objective was to ascertain the current practices of donor vein assessment and central venous catheter (CVC) usage. Methods: The American Society for Apheresis (ASFA) HPC subcommittee created an electronic survey about precollection vein assessment and line placement, care, and removal in autologous and allogeneic donors. It was distributed to >5,000 possible participants, with one response analyzed per institution. Results: One hundred centers performing autologous and/or allogeneic procedures provided adequate responses for analysis. Donor vein assessment is most often performed by apheresis staff more than 1 week prior to collection. For patients with questionable access, the next step performed most often is secondary assessment for autologous procedures and CVC placement for allogeneic procedures. Most centers use interventional radiology to place CVCs in jugular veins on collection day with placement verification through electronic medical records. Verbal and written postinsertion CVC care instructions are routinely provided. The apheresis team frequently provides postinsertion CVC care for autologous patients. Heparin is used most often for CVC lock. When used, tissue plasminogen activator is usually instilled for up to 60 min. Conclusion: These data summarize the largest single survey of donor vein assessment at institutions performing HPC collections by apheresis. The variations identified in donor venous access practice warrant further investigation and consensus to establish best practices. J. Clin. Apheresis 31:529–534, 2016.Keywords
This publication has 12 references indexed in Scilit:
- Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantationBone Marrow Transplantation, 2013
- Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramBlood, 2009
- Large‐volume‐apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patientsJournal of Clinical Apheresis, 2009
- Progenitor cell recruitment during individualized high‐flow, very‐large‐volume apheresis for autologous transplantation improves collection efficiencyTransfusion, 2006
- Factors affecting PBSC mobilization and collection in healthy donorsTransfusion and Apheresis Science, 2005
- Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The Pediatric Blood and Marrow Transplant Consortium Experience (PBMTC) 1996–2003Bone Marrow Transplantation, 2004
- Differences between graft product and donor side effects following bone marrow or stem cell donationBone Marrow Transplantation, 2003
- Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patientsIntensive Care Medicine, 2002
- Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesBone Marrow Transplantation, 2001
- Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donorsBone Marrow Transplantation, 1999